Welcome to our dedicated page for Smith & Nephew news (Ticker: SNN), a resource for investors and traders seeking the latest updates and insights on Smith & Nephew stock.
Smith & Nephew plc (SNN), a global leader in medical technology, provides innovative solutions in orthopedic reconstruction, sports medicine, and advanced wound care. This dedicated news hub offers investors and healthcare professionals timely access to SNN's official announcements and market-moving developments.
Track critical updates including quarterly earnings, product approvals, and strategic partnerships that shape the future of surgical technologies. Our curated feed ensures you never miss regulatory milestones, clinical trial results, or executive leadership changes impacting SNN's global operations.
Bookmark this page for streamlined access to verified information directly affecting SNN's market position. Regular updates provide insights into how the company addresses healthcare challenges through robotics, digital surgery platforms, and patient-centric device innovations.
On April 24, 2023, Smith+Nephew (LSE:SN, NYSE:SNN) unveiled the CORI™ Digital Tensioner, a groundbreaking device designed for robotic-assisted knee surgeries. This innovative technology allows surgeons to measure ligament tension before bone cutting, enhancing surgical precision and reducing variability by 64% compared to manual methods. The tensioner provides quantifiable joint laxity data, facilitating better surgical planning. Dr. Steven Haas praised the device for its capability to deliver objective gap data, marking a significant advancement in knee replacement procedures. The first commercial use occurred in Arizona, highlighting its practical application in a clinical setting. This launch underscores Smith+Nephew's commitment to improving patient outcomes through innovative technologies.
FAQ
What is the current stock price of Smith & Nephew (SNN)?
What is the market cap of Smith & Nephew (SNN)?
